An Age-Stratified Data Collection Study in Adult Males and Females, Ages 18 and Above to Establish a Normative Database Using the 3D Optical Coherence Tomography 3D OCT-1000 Mark II

November 8, 2010 updated by: Topcon Corporation
To collect three dimensional retinal measurements of the optic disc and the macula lutea on healthy normal subjects using the 3D OCT-1000 Mark II for the purpose of developing a normative database that is stratified by age.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

180

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • La Jolla, California, United States, 92037
        • Shiley Eye Center UCSD
    • Kansas
      • Overland Park, Kansas, United States, 66211
        • Durrie Vision
    • New York
      • New York, New York, United States, 10003
        • Glaucoma Associates of New York
      • New York, New York, United States, 10036
        • SUNY
      • New York, New York, United States, 10022
        • Vitreous-Retina-Macula Consultants of New York, P.C.
    • Wisconsin
      • Milwaukee, Wisconsin, United States, 53226
        • Eye Institute/Medical College of WI

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

180 male and female volunteers from 6 centers with normal, healthy eyes form six age groups, aged 18 years or older.

Description

Inclusion Criteria:

  • Male and Females at least 18 years of age;
  • Must be a member of one of the 3 ethnic groups: Caucasian, Hispanic or African American. Asians, Eastern Indians, and Native Americans have been excluded from this study;
  • Signed, written informed consent obtained for the study;
  • BSCVA of 20/40 or better in both eyes;
  • Intraocular pressure (IOP) ≤ 21 mm Hg in both eyes.

Exclusion Criteria:

  • Ocular disease;
  • Cataract on slit lamp exam with a corresponding loss of BSCVA worse than 20/25;
  • Corneal surface disruption precluding imaging;
  • Prior ocular surgery except uncomplicated phacoemulsification or strabismus surgery;
  • Prior corneal refractive surgery of any type;
  • Family history of glaucoma among first generation relatives;
  • Current history of an acute or chronic disease or illness that would confound the normative outcome(s) of the study;
  • Current use of systemic medications that may confound the outcome of the study;
  • Nystagmus or any other condition that would prevent a steady gaze during study tests or measurements;
  • Current history of inflammation or infection of the eye or eyelids; injury to the eye.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Normal Healthy Volunteers

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
A normative dataset containing a statistical description of expected norms of retinal nerve fiber layer (RNFL) and macula lutea thickness, stratified by age.
Time Frame: 12 Months
12 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Robert Weinreb, M.D., University of California, San Diego; Shiley Eye Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2009

Primary Completion (Anticipated)

March 1, 2010

Study Completion (Anticipated)

November 1, 2010

Study Registration Dates

First Submitted

December 8, 2009

First Submitted That Met QC Criteria

December 8, 2009

First Posted (Estimate)

December 9, 2009

Study Record Updates

Last Update Posted (Estimate)

November 10, 2010

Last Update Submitted That Met QC Criteria

November 8, 2010

Last Verified

November 1, 2010

More Information

Terms related to this study

Other Study ID Numbers

  • NDB-001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

3
Subscribe